‌

Morgan and Mendel Genomics, Inc. SBIR Phase I Award, November 2021

A SBIR Phase I contract was awarded to Morgan and Mendel Genomics, Inc. in November, 2021 for $49,955.0 USD from the U.S. Department of Defense and United States Air Force.

Overview Structured Data Issues Contributors

sbir.gov/node/2215485

Is a

SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient

‌

Morgan and Mendel Genomics, Inc.

Government Agency

U.S. Department of Defense

Government Branch

United States Air Force

Award Type

SBIR0

Contract Number (US Government)

FA864922P02560

Award Phase

Phase I0

Award Amount (USD)

49,9550

Date Awarded

November 3, 2021

End Date

February 7, 2022

Morgan and Mendel Genomics (MMG) is a functional genomics company developing cutting edge science to identify genetic disruptions in human cells with high sensitivity and specificity, low cost, and rapid performance time. MMG’s two novel blood tests, Canc

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like Morgan and Mendel Genomics, Inc. SBIR Phase I Award, November 2021

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API